WebJun 28, 2024 · The original SNAP-HT trial was designed to assess feasibility and safety of a self-management digital intervention in the postnatal period, but exploring the impact of the intervention on BP was an important secondary outcome. 25 The finding in SNAP-HT of a persistently lower diastolic BP at 6 months, when almost all women had stopped … WebSep 1, 2024 · The aim of this trial is to examine whether antihypertensive medication reduction is possible in older patients without significant changes in blood pressure control at follow-up, and to determine if a reduction in medication can achieve a proportion of participants with clinically safe blood pressure levels at 12-week follow up. Introduction …
Ten tips to optimize vasopressors use in the critically ill patient ...
WebThe present study tests the system's effectiveness in a randomized, controlled trial in diabetic patients with uncontrolled systolic hypertension. Of 244 subjects screened for eligibility, 110 (45%) were randomly allocated to the intervention (n = 55) or control (n = 55) group, and 105 (95.5%) completed the 1-year outcome visit. WebApr 20, 2024 · This study used data from the OPTiMISE trial to examine whether short-term outcomes of deprescribing vary by drug class and dose of medication withdrawn. Methods: The OPTiMISE trial included patients aged ≥80 years with controlled systolic blood pressure (SBP; <150 mmHg), receiving ≥2 antihypertensive medications. This study compared SBP ... how do you sign evening in asl
Hypertension Optimal Treatment (HOT) Study Hypertension
WebCost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial Sue Jowett, Shahela Kodabuckus, Gary A. Ford, F.D. Richard Hobbs, Rupert A Payne, James P. Sheppard * WebAug 18, 2024 · 18 The rationale for OPTiMISE was that patients with frailty and multimorbidity are not well represented in previous blood pressure lowering trials and may in fact benefit from fewer treatments ... WebMar 10, 2024 · The OPTiMISE (Optimising Treatment for Mild Systolic Hypertension in the Elderly) trial sought to address this evidence gap through a randomized, open label, … how do you sign for bigy digital